QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Present Virtually at H.C. Wainwright 23rd Annual Global Investment Conference
Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company focused on advancing psychedelic pharmaceutical therapeutics for various psychiatric and neurological conditions, today announced that on Monday, September 13, 2021, Chief Executive Officer Doug Drysdale will be presenting virtually at the H.C. Wainwright 23rd Annual Global Investment Conference. The presentation will be webcast on-demand beginning at 7:00 AM ET on September 13, and will be available for 90 days at https://ibn.fm/cWDdt To view the full press release, visit https://ibn.fm/2VJSS About Cybin Inc. Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery…